Clinical Trial Update: Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

View source ↗

Summary

This completed prospective registry study evaluates how the MammaPrint genomic test influences adjuvant and neoadjuvant treatment decisions in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Agendia | Conditions: Breast Cancer | Status: COMPLETED